eMedicine Specialties > Pediatrics: Cardiac Disease and Critical Care Medicine > Cardiology

Aortic Stenosis, Supravalvar

Author: Gautam K Singh, MD, DCh, MRCP, FACC, Associate Professor of Pediatrics, Division of Cardiology, Director of Noninvasive Imaging Research, Co-director of Echocardiography Laboratory, Washington University School of Medicine; Attending Faculty, Department of Pediatrics, Division of Cardiology, St Louis Children's Hospital
Contributor Information and Disclosures

Updated: Oct 27, 2009

Introduction

Background

Supravalvular aortic stenosis (SVAS) is a fixed form of congenital left ventricular outflow tract (LVOT) obstruction that occurs as a localized or a diffuse narrowing of the ascending aorta beyond the superior margin of the sinuses of Valsalva.1 It accounts for less than 7% of all fixed forms of congenital LVOT obstructive lesions.2 Supravalvular aortic stenosis may occur sporadically, as a manifestation of elastin arteriopathy, or as part of Williams syndrome (also known as Williams-Beuren syndrome), a genetic disorder with autosomal dominant inheritance.

Two-dimensional suprasternal echocardiographic im...

Two-dimensional suprasternal echocardiographic image of supravalvular aortic stenosis.

Two-dimensional suprasternal echocardiographic im...

Two-dimensional suprasternal echocardiographic image of supravalvular aortic stenosis.


Aortogram of a patient with supravalvular aortic ...

Aortogram of a patient with supravalvular aortic stenosis and dilated sinus of Valsalva.

Aortogram of a patient with supravalvular aortic ...

Aortogram of a patient with supravalvular aortic stenosis and dilated sinus of Valsalva.


Anatomy of subtypes

Supravalvular aortic stenosis has 3 commonly recognized morphologic forms. An external hourglass deformity with a corresponding luminal narrowing of the aorta at a level just distal to the coronary artery ostia is present in 50-75% of patients.3 In approximately 25% of patients, a fibrous diaphragm is present just distal to the coronary artery ostia. In fewer than 25% of patients, a diffuse narrowing along a variable length of ascending aorta is present. Similarly, the following 3 anatomic subtypes of coronary lesions have been recognized in supravalvular aortic stenosis:4

  • Circumferential narrowing of the left coronary ostium
  • Ostial obstruction due to fusion of the aortic cusp to the supravalvular ridge
  • Diffuse narrowing of the left coronary artery

Pathophysiology

The origins of the coronary arteries proximal to the obstruction site have the same systolic pressure as the left ventricle (LV).3 Consequently, over time they become dilated and tortuous with hypertrophy and intimal thickening, predisposing them to premature atherosclerosis. The hemodynamic consequences of coronary artery changes are manifested by increased total mean coronary flow but significantly decreased diastolic coronary flow, which is the major determinant of the development of myocardial ischemia. Concentric LV hypertrophy caused by supravalvular aortic stenosis exacerbates the problem of myocardial ischemia. In most patients, the jet of blood flow from supravalvular aortic stenosis demonstrates preferential trajectory into brachiocephalic vessels, the so-called Coanda effect; this accounts for a marked increase in the right upper extremity systolic pressure relative to the left.5

Natural history

Supravalvular stenosis is a progressive lesion, whereas peripheral pulmonary artery stenosis remains unchanged or reduces in severity over time.6 The risk of sudden cardiac death, including in operated patients, is 1 case per 1,000 patient years and is 25-100 times higher than in the normal population.7 Patients with supravalvular aortic stenosis are vulnerable to cardiac arrest or significant hemodynamic instability during induction of anesthesia and cardiac catheterization. Anatomic abnormalities that predispose individuals with supravalvular aortic stenosis and Williams syndrome to sudden death include coronary artery stenosis and severe biventricular outflow tract obstruction. The mechanisms for sudden death for both anatomic subgroups are believed to include myocardial ischemia, decreased cardiac output, and arrhythmia.8

Frequency

United States

The crude incidence of congenital heart defects is approximately 8 per 1000 live births, and supravalvular aortic stenosis accounts for less than 0.05% of these defects. The sporadic form of supravalvular aortic stenosis is more common than the autosomal dominant form.

International

The international incidence of supravalvular aortic stenosis is not clearly known.

Mortality/Morbidity

In one series, the actuarial survival rate following operative repair of supravalvular aortic stenosis was found to be approximately 85% at 15 years.9 The mortality rate is higher for the diffuse type of supravalvular aortic stenosis than the localized type. Aortic valve insufficiency can be present in approximately 25% of patients but is usually nonprogressive after surgical relief of supravalvular aortic stenosis.

Sex

Supravalvular aortic stenosis has no sex predilection.

Age

Patients with supravalvular aortic stenosis usually become symptomatic during childhood, but SVAS is usually identified during infancy in cases associated with Williams syndrome. The diagnosis of Williams syndrome can be established with cytogenic analysis; therefore, this diagnosis can be made in utero using chorionic villus tissue. Therefore, particularly in patients with Williams syndrome, supravalvular aortic stenosis can be detected prenatally if it is revealed with fetal echocardiography.

Clinical

History

Symptoms caused by supravalvar aortic stenosis (SVAS) usually develop in childhood and only rarely do so in infancy; however, some patients may develop symptoms in the second or third decade of life.

  • Most pediatric patients present because of a heart murmur or the features of Williams syndrome.
  • Dyspnea on exertion, angina, and syncope develop in the course of the disease if untreated.
    • These symptoms indicate at least a moderate degree of left ventricular (LV) outflow tract (LVOT) obstruction.
    • Because of the coronary artery involvement, angina may arise early and more often than in other obstructive LVOT lesions.
    • Because of the risk of sudden death in supravalvular aortic stenosis, the development of angina and syncope should prompt immediate investigation.
  • Patients with Williams syndrome may additionally develop systemic hypertension and involvement of joints, peripheral pulmonary artery stenosis, coarctation of aorta, and mitral insufficiency.

Physical

  • Asymmetric upper extremities pulses: Discrepancies between carotid pulsations and upper extremities pulses and blood pressure are the characteristic clinical findings of supravalvular aortic stenosis. The jet of blood flow from supravalvular aortic stenosis demonstrates preferential trajectory into brachiocephalic (innominate) artery (ie, Coanda effect), which accounts for the discrepancies.
  • Precordium: The precordium is usually hyperdynamic, and the apex of the heart is displaced laterally and inferiorly because of ventricular hypertrophy. A thrill in the suprasternal notch is usually felt because of the trajectory of the blood flow jet from supravalvular aortic stenosis.
  • Heart sounds: The first heart sound is generally normal. A narrowly split, single, or paradoxically split second heart sound and a fourth heart sound are present in severe supravalvular aortic stenosis.
  • Heart murmurs: An ejection click is absent in supravalvular aortic stenosis. The characteristic systolic murmur of supravalvular aortic stenosis is crescendo-decrescendo in shape, low pitched, and best heard at the base of the heart sited higher than in valvular aortic stenosis. It mainly radiates to the right carotid artery and tends to peak during the last two thirds of the ventricular systole if the obstruction is severe. A high-pitched, short, early diastolic aortic regurgitation murmur is uncommon in supravalvular aortic stenosis.

Causes

The precise etiology of supravalvular aortic stenosis is unknown. Its high association with Williams syndrome, in which an elastin gene mutation is present, suggests that defective connective tissue formation contributes to its pathology.

  • Supravalvular aortic stenosis may occur sporadically or as part of Williams syndrome, with autosomal dominant inheritance.
    • Williams syndrome is a genetic disorder caused by a hemizygous deletion or mutation of the elastin gene at band 7q11.10
    • Other features of Williams syndrome include elfin facies, mental retardation, outgoing "cocktail party" personality, systemic hypertension, and progressive joint involvement.
    • Other cardiovascular anomalies in Williams syndrome consist of multiple stenoses of peripheral pulmonary arteries, stenosis of origins of carotid, coronary and subclavian arteries, and coarctation of aorta.
    • The familial form of supravalvular aortic stenosis caused by an autosomal dominant inheritance but without other features of Williams syndrome is a less common presentation.
    • The sporadic form of supravalvular aortic stenosis is the most common (>50%) presentation. Patients may have associated peripheral pulmonary artery stenosis but show no other features of Williams syndrome.
  • The genetic predisposition discussed above is the only known risk factor for acquiring supravalvular aortic stenosis.

More on Aortic Stenosis, Supravalvar

Overview: Aortic Stenosis, Supravalvar
Differential Diagnoses & Workup: Aortic Stenosis, Supravalvar
Treatment & Medication: Aortic Stenosis, Supravalvar
Follow-up: Aortic Stenosis, Supravalvar
Multimedia: Aortic Stenosis, Supravalvar
References

References

  1. Micale L, Turturo MG, Fusco C, et al. Identification and characterization of seven novel mutations of elastin gene in a cohort of patients affected by supravalvular aortic stenosis. Eur J Hum Genet. Oct 21 2009;[Medline].

  2. Peterson TA, Todd DB, Edwards JE. Supravalvular aortic stenosis. J Thorac Cardiovasc Surg. Nov 1965;50(5):734-41. [Medline].

  3. Edwards JE. Pathology of left ventricular outflow tract obstruction. Circulation. 1965;31:586-99.

  4. Thistlethwaite PA, Madani MM, Kriett JM, Milhoan K, Jamieson SW. Surgical management of congenital obstruction of the left main coronary artery with supravalvular aortic stenosis. J Thorac Cardiovasc Surg. Dec 2000;120(6):1040-6. [Medline].

  5. Gersony WM, Hayes CJ, Driscoll DJ, et al. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation. Feb 1993;87(2 Suppl):I121-6. [Medline].

  6. Wren C, Oslizlok P, Bull C. Natural history of supravalvular aortic stenosis and pulmonary artery stenosis. J Am Coll Cardiol. Jun 1990;15(7):1625-30. [Medline].

  7. Wessel TR, Arant CB, Olson MB, et al. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. JAMA. Sep 8 2004;292(10):1179-87. [Medline].

  8. Bird LM, Billman GF, Lacro RV, et al. Sudden death in Williams syndrome: report of ten cases. J Pediatr. Dec 1996;129(6):926-31. [Medline].

  9. Brown JW, Ruzmetov M, Vijay P, et al. Surgical repair of congenital supravalvular aortic stenosis in children. Eur J Cardiothorac Surg. Jan 2002;21(1):50-6. [Medline].

  10. Ewart AK, Morris CA, Atkinson D, et al. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet. Sep 1993;5(1):11-6. [Medline].

  11. Jureidini SB, Marino CJ, Singh GK, et al. Main coronary artery and coronary ostial stenosis in children: detection by transthoracic color flow and pulsed Doppler echocardiography. J Am Soc Echocardiogr. Apr 2000;13(4):255-63. [Medline].

  12. Tani LY, Minich LL, Pagotto LT, Shaddy RE. Usefulness of doppler echocardiography to determine the timing of surgery for supravalvar aortic stenosis. Am J Cardiol. Jul 1 2000;86(1):114-6. [Medline].

  13. [Guideline] Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. Aug 1 2006;114(5):e84-231. [Medline].

  14. McElhinney DB, Petrossian E, Tworetzky W, Silverman NH, Hanley FL. Issues and outcomes in the management of supravalvar aortic stenosis. Ann Thorac Surg. Feb 2000;69(2):562-7. [Medline].

  15. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. Jun 2007;138(6):739-45, 747-60. [Medline][Full Text].

  16. Dridi SM, Foucault Bertaud A, Igondjo Tchen S, et al. Vascular wall remodeling in patients with supravalvular aortic stenosis and Williams Beuren syndrome. J Vasc Res. May-Jun 2005;42(3):190-201. [Medline].

  17. French JW, Guntheroth WG. An explanation of asymmetric upper extremity blood pressures in supravalvular aortic stenosis: the Coanda effect. Circulation. Jul 1970;42(1):31-6. [Medline].

  18. Keane JF, Fellows KE, LaFarge CG, et al. The surgical management of discrete and diffuse supravalvar aortic stenosis. Circulation. Jul 1976;54(1):112-7. [Medline].

  19. Kirklin JW, Barratt-Boyes BG. Congenital aortic stenosis. In: Cardiac Surgery. Vol 2. 2nd ed. New York, NY: Churchill Livingstone Inc; 1993:1195-1238.

  20. Latson LA. Aortic stenosis: Valvular, supravalvular, fibromuscular subvalvular. In: Garson A, Bricker JT, McNamara DG, eds. The Science and Practice of Pediatric Cardiology. Philadelphia, Pa: Lea & Febiger; 1990:1334-52.

  21. Rodriguez-Revenga L, Badenas C, Carrio A, Mila M. Elastin mutation screening in a group of patients affected by vascular abnormalities. Pediatr Cardiol. Nov-Dec 2005;26(6):827-31. [Medline].

  22. Sugiyama H, Veldtman GR, Norgard G, et al. Bladed balloon angioplasty for peripheral pulmonary artery stenosis. Catheter Cardiovasc Interv. May 2004;62(1):71-7. [Medline].

  23. Tani LY, Minich LL, Pagotto LT, Shaddy RE. Usefulness of doppler echocardiography to determine the timing of surgery for supravalvar aortic stenosis. Am J Cardiol. Jul 1 2000;86(1):114-6. [Medline].

Further Reading

Keywords

supravalvular aortic stenosis, SVAS, left ventricular outflow tract obstruction, LVOT obstruction, Williams syndrome, Williams-Beuren syndrome, atherosclerosis, myocardial ischemia, Coanda effect, diffuse peripheral pulmonary artery stenosis

Contributor Information and Disclosures

Author

Gautam K Singh, MD, DCh, MRCP, FACC, Associate Professor of Pediatrics, Division of Cardiology, Director of Noninvasive Imaging Research, Co-director of Echocardiography Laboratory, Washington University School of Medicine; Attending Faculty, Department of Pediatrics, Division of Cardiology, St Louis Children's Hospital
Gautam K Singh, MD, DCh, MRCP, FACC is a member of the following medical societies: American College of Cardiology, American Heart Association, American Society of Echocardiography, and Royal College of Physicians
Disclosure: Nothing to disclose.

Medical Editor

Charles I Berul, MD, Professor of Pediatrics, George Washington University School of Medicine; Chief, Division of Cardiology, Children's National Medical Center
Charles I Berul, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, Cardiac Electrophysiology Society, Heart Rhythm Society, Pediatric and Congential Electrophysiology Society, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

John W Moore, MD, MPH, Professor of Clinical Pediatrics, Section of Pediatric Cardiology, Department of Pediatrics, University of California San Diego School of Medicine; Director of Cardiology, Rady Children's Hospital
John W Moore, MD, MPH is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, and Society for Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

CME Editor

Gilbert Z Herzberg, MD, Assistant Professor, Department of Pediatrics, Section of Pediatric Cardiology, New York Medical College; Consulting Staff, Department of Pediatrics, Sound Shore Medical Center
Gilbert Z Herzberg, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Chief Editor

Steven R Neish, MD, SM, Director of Pediatric Cardiology Fellowship Program, Associate Professor, Department of Pediatrics, Baylor College of Medicine
Steven R Neish, MD, SM is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, and American Heart Association
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.